| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.4155/BIO.14.278 |
| P698 | PubMed publication ID | 25529882 |
| P50 | author | Ana Concheiro-Guisan | Q59162445 |
| P2093 | author name string | Marta Concheiro | |
| P2860 | cites work | The use of psychotropic medication during pregnancy: how about the newborn? | Q24625025 |
| Systematic review of prenatal cocaine exposure and adolescent development | Q26998102 | ||
| Assessment of exposure to drugs of abuse during pregnancy by hair analysis in a Mediterranean island. | Q30412419 | ||
| Neonatal abstinence syndrome after methadone or buprenorphine exposure | Q30499416 | ||
| The role of alternative specimens in toxicological analysis. | Q33338053 | ||
| Quantification of nicotine, cotinine, trans-3'-hydroxycotinine, nornicotine and norcotinine in human meconium by liquid chromatography/tandem mass spectrometry | Q33439159 | ||
| Development and validation of a liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry method for simultaneous analysis of 10 amphetamine-, methamphetamine- and 3,4-methylenedioxymethamphetamine-related (MDMA) analyt | Q33439633 | ||
| Effects of prenatal methamphetamine exposure on behavioral and cognitive findings at 7.5 years of age. | Q33670954 | ||
| Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis | Q33692098 | ||
| Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis | Q33937207 | ||
| A review of the effects of prenatal cocaine exposure among school-aged children | Q34097625 | ||
| Cocaine use during pregnancy assessed by hair analysis in a Canary Islands cohort | Q34122024 | ||
| Prenatal substance abuse: short- and long-term effects on the exposed fetus | Q34329692 | ||
| The impact of exposure to addictive drugs on future generations: Physiological and behavioral effects | Q34354237 | ||
| Confirmation of gestational exposure to alprazolam by analysis of biological matrices in a newborn with neonatal sepsis | Q34622095 | ||
| Maternal methadone dose, placental methadone concentrations, and neonatal outcomes. | Q34626408 | ||
| Drug abuse's smallest victims: in utero drug exposure | Q34808681 | ||
| Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes | Q35112886 | ||
| Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in human placenta by liquid chromatography mass spectrometry | Q35175087 | ||
| Effect of hydrolysis on identifying prenatal cannabis exposure | Q35184670 | ||
| Development and validation of a liquid chromatography mass spectrometry assay for the simultaneous quantification of methadone, cocaine, opiates and metabolites in human umbilical cord | Q35184678 | ||
| Scientific Working Group for Forensic Toxicology (SWGTOX) standard practices for method validation in forensic toxicology | Q45268978 | ||
| Fatty acid ethyl esters (FAEEs) as markers for alcohol in meconium: method validation and implementation of a screening program for prenatal drug exposure. | Q45911221 | ||
| Comparison of drugs of abuse detection in meconium by EMIT II and ELISA. | Q46048671 | ||
| Liquid chromatography with tandem mass spectrometric detection for the measurement of ethyl glucuronide and ethyl sulfate in meconium: new biomarkers of gestational ethanol exposure? | Q46213576 | ||
| Quantitation of benzodiazepines in urine, serum, plasma, and meconium by LC-MS-MS. | Q46421940 | ||
| Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium | Q46799028 | ||
| Alternative matrices for cocaine, heroin, and methadone in utero drug exposure detection | Q46869389 | ||
| Buprenorphine and norbuprenorphine in hair of pregnant women and their infants after controlled buprenorphine administration | Q46962301 | ||
| A rapid assay for the simultaneous determination of nicotine, cocaine and metabolites in meconium using disposable pipette extraction and gas chromatography-mass spectrometry (GC-MS). | Q47945346 | ||
| Simultaneous determination of opiates, methadone, amphetamines, cocaine, and metabolites in human placenta and umbilical cord by LC-MS/MS. | Q48091451 | ||
| Simultaneous detection of seventeen drugs of abuse and metabolites in hair using solid phase micro extraction (SPME) with GC/MS. | Q48217532 | ||
| Drugs of abuse detection in meconium: a comparison between ELISA and biochip microarray | Q48297109 | ||
| Development and practical application of accelerated solvent extraction for the isolation of cocaine/crack biomarkers in meconium samples | Q50707129 | ||
| A new method for quantifying prenatal exposure to ethanol by microwave-assisted extraction (MAE) of meconium followed by gas chromatography-mass spectrometry (GC-MS). | Q50754580 | ||
| Perinatal effects of combined use of heroin, methadone, and amphetamine during pregnancy and quantitative measurement of metabolites in hair. | Q51346569 | ||
| Detection of cocaine and its metabolites in amniotic fluid and umbilical cord tissue. | Q51547396 | ||
| Determination of cocaine and its major metabolite, benzoylecgonine, in amniotic fluid, umbilical cord blood, umbilical cord tissue, and neonatal urine: a case study. | Q51674749 | ||
| Nicotine and metabolites in paired umbilical cord tissue and meconium specimens. | Q52713432 | ||
| A liquid chromatography tandem mass spectrometry method for the simultaneous quantification of 20 drugs of abuse and metabolites in human meconium | Q35190477 | ||
| Simultaneous quantification of methadone, cocaine, opiates, and metabolites in human placenta by liquid chromatography-mass spectrometry | Q35215304 | ||
| Prenatal exposure to arecoline (areca nut alkaloid) and birth outcomes | Q35296858 | ||
| Drug transfer and metabolism by the human placenta. | Q35788063 | ||
| Validation of a novel method to identify in utero ethanol exposure: simultaneous meconium extraction of fatty acid ethyl esters, ethyl glucuronide, and ethyl sulfate followed by LC-MS/MS quantification | Q35962908 | ||
| State of the art in hair analysis for detection of drug and alcohol abuse. | Q36453516 | ||
| Bioanalytical procedures for monitoring in utero drug exposure | Q36763641 | ||
| Biological matrices for the evaluation of in utero exposure to drugs of abuse | Q37016992 | ||
| Methamphetamine detection in maternal and neonatal hair: implications for fetal safety. | Q37174701 | ||
| Validation and application of a method for the determination of buprenorphine, norbuprenorphine, and their glucuronide conjugates in human meconium | Q37210263 | ||
| Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine-glucuronide and norbuprenorphine-glucuronide in human umbilical cord by liquid chromatography tandem mass spectrometry | Q37236830 | ||
| Correlations of maternal buprenorphine dose, buprenorphine, and metabolite concentrations in meconium with neonatal outcomes | Q37272782 | ||
| Determination of amphetamine and methamphetamine in umbilical cord using liquid chromatography-tandem mass spectrometry | Q37434781 | ||
| Effects of prenatal cocaine/polydrug exposure on substance use by age 15. | Q37614746 | ||
| Consequences of prenatal substance use. | Q38036441 | ||
| Role of LC-MS/MS in hair testing for the determination of common drugs of abuse and other psychoactive drugs. | Q38125762 | ||
| Chronic opioid use during pregnancy: maternal and fetal implications | Q38131145 | ||
| Neonatal and longer term management following substance misuse in pregnancy | Q38151388 | ||
| Effects of addictive substances during pregnancy and infancy and their analysis in biological materials. | Q38155439 | ||
| Hair ethyl glucuronide levels as a marker for alcohol use and abuse: a review of the current state of the art. | Q38163213 | ||
| Quantitation of fatty acid ethyl esters in human meconium by an improved liquid chromatography/tandem mass spectrometry | Q38483710 | ||
| Ethanol cytotoxic effect on trophoblast cells | Q39038846 | ||
| Nails of newborns in monitoring drug exposure during pregnancy | Q39210849 | ||
| Altered reward processing in adolescents with prenatal exposure to maternal cigarette smoking | Q39399664 | ||
| Umbilical cord monitoring of in utero drug exposure to buprenorphine and correlation with maternal dose and neonatal outcomes | Q42728180 | ||
| Broad-spectrum drug screening of meconium by liquid chromatography with tandem mass spectrometry and time-of-flight mass spectrometry | Q42975289 | ||
| Determination of eight fatty acid ethyl esters in meconium samples by headspace solid-phase microextraction and gas chromatography-mass spectrometry. | Q43022361 | ||
| Opioid detection in maternal and neonatal hair and meconium: characterization of an at-risk population and implications to fetal toxicology | Q43085960 | ||
| Nicotine and its metabolites in amniotic fluid at birth--assessment of prenatal tobacco smoke exposure | Q43158765 | ||
| Quantification of fatty acid ethyl esters (FAEE) and ethyl glucuronide (EtG) in meconium from newborns for detection of alcohol abuse in a maternal health evaluation study | Q43166541 | ||
| Ethyl glucuronide determination in meconium and hair by hydrophilic interaction liquid chromatography-tandem mass spectrometry. | Q43198670 | ||
| Gas chromatography-mass spectrometry assay for the simultaneous quantification of drugs of abuse in human placenta at 12th week of gestation | Q43200069 | ||
| Neonatal hair analysis by liquid chromatography-high-resolution mass spectrometry to reveal gestational exposure to venlafaxine | Q43255304 | ||
| Cocaine and opiates use in pregnancy: detection of drugs in neonatal meconium and urine. | Q43268563 | ||
| Transplacental transfer and metabolism of buprenorphine | Q43830093 | ||
| Detection of cocaine analytes and opiates in nails from postmortem cases | Q44209986 | ||
| Maternal hair analysis for the detection of illicit drugs, medicines, and alcohol exposure during pregnancy. | Q44425101 | ||
| Simultaneous quantification of amphetamine and methamphetamine in meconium using ISOLUTE HM-N-supported liquid extraction columns and GC-MS. | Q44940650 | ||
| The effect of controlled drugs on the unborn child and fetus | Q44993923 | ||
| P433 | issue | 23 | |
| P304 | page(s) | 3133-3153 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | Bioanalysis | Q18616741 |
| P1476 | title | Bioanalysis during pregnancy: recent advances and novel sampling strategies | |
| P478 | volume | 6 |
| Q39422252 | Bioanalysis for cocaine, opiates, methadone, and amphetamines exposure detection during pregnancy. |
| Q47561553 | DNA methylation as a predictor of fetal alcohol spectrum disorder. |
| Q47921404 | Detection of in utero cannabis exposure by umbilical cord analysis. |
| Q64230197 | Opioid Use in Pregnant Women and Neonatal Abstinence Syndrome-A Review of the Literature |
| Q89727781 | Prenatal Drinking in the Northern Plains: Differences Between American Indian and Caucasian Mothers |
Search more.